Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T21:03:17.032Z.
Calculation as of: 2026-10-06T21:03:17.032Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 82e50dad054807a2d9cfcf78e4a189ad4456f1f756e397ab71e696e9b4df84c5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2023-03-31.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
5.75x
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Cartesian Therapeutics, Inc.
Market Cap
$198.33M
EV/EBITDA Ratio
N/A
TTM Avg
5.75x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$205.80M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$190.07M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$207.27M
EV/EBITDA Ratio
15.10x
TTM Avg
13.21x
3Y Avg
12.70x
5Y Avg
13.38x
Market Cap
$189.11M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | $198.33M | N/A | 5.75x | N/A | N/A |
| Exagen Inc. (XGN)vs › | $197.87M | N/A | N/A | N/A | N/A |
| Surrozen, Inc. (SRZN)vs › | $197.18M | N/A | N/A | N/A | N/A |
| Alector, Inc. (ALEC)vs › | $200.96M | N/A | 16.55x | 16.55x | 16.55x |
| RxSight, Inc. (RXST)vs › | $192.49M | N/A | N/A | N/A | N/A |
| Whitehawk Therapeutics Inc (WHWK)vs › | $205.80M | N/A | N/A | N/A | N/A |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $190.07M | N/A | N/A | N/A | N/A |
| Pro-Dex, Inc. (PDEX)vs › | $207.27M | 15.10x | 13.21x | 12.70x | 13.38x |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | N/A | N/A | N/A | N/A |
| Electra Therapeutics Inc. (ETRA)vs › | $208.31M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2023-03-31 | 7.89x |
| 2023-03-30 | 7.46x |
| 2023-03-29 | 6.85x |
| 2023-03-28 | 6.94x |
| 2023-03-27 | 7.37x |
| 2023-03-24 | 8.06x |
| 2023-03-23 | 8.40x |
| 2023-03-22 | 8.06x |
| 2023-03-21 | 6.77x |
| 2023-03-20 | 6.94x |
| 2023-03-17 | 7.54x |
| 2023-03-16 | 8.14x |
| 2023-03-15 | 7.97x |
| 2023-03-14 | 8.49x |
| 2023-03-13 | 8.32x |
| 2023-03-10 | 7.71x |
| 2023-03-09 | 8.83x |
| 2023-03-08 | 9.26x |
| 2023-03-07 | 9.01x |
| 2023-03-06 | 8.92x |
| 2023-03-03 | 9.26x |
| 2023-03-02 | 9.52x |
| 2023-03-01 | 9.69x |
| 2023-02-28 | 9.95x |
| 2023-02-27 | 9.61x |
| 2023-02-24 | 9.26x |
| 2023-02-23 | 9.69x |
| 2023-02-22 | 10.04x |
| 2023-02-21 | 10.55x |
| 2023-02-17 | 10.98x |
| 2023-02-16 | 10.98x |
| 2023-02-15 | 11.93x |
| 2023-02-14 | 12.02x |
| 2023-02-13 | 12.19x |
| 2023-02-10 | 11.84x |
| 2023-02-09 | 11.07x |
| 2023-02-08 | 10.81x |
| 2023-02-07 | 12.02x |
| 2023-02-06 | 11.67x |
| 2023-02-03 | 11.76x |
| 2023-02-02 | 11.93x |
| 2023-02-01 | 11.67x |
| 2023-01-31 | 11.16x |
| 2023-01-30 | 11.07x |
| 2023-01-27 | 11.24x |
| 2023-01-26 | 10.73x |
| 2023-01-25 | 10.64x |
| 2023-01-24 | 11.50x |
| 2023-01-23 | 10.98x |
| 2023-01-20 | 10.64x |
| 2023-01-19 | 9.95x |
| 2023-01-18 | 10.21x |
| 2023-01-17 | 10.47x |
| 2023-01-13 | 10.47x |
| 2023-01-12 | 9.26x |
| 2023-01-11 | 8.57x |
| 2023-01-10 | 7.63x |
| 2023-01-09 | 7.37x |
| 2023-01-06 | 6.51x |
| 2023-01-05 | 5.91x |
| 2023-01-04 | 5.82x |
| 2023-01-03 | 5.82x |
| 2022-12-30 | 3.37x |
| 2022-12-29 | 3.37x |
| 2022-12-28 | 2.63x |
| 2022-12-27 | 2.45x |
| 2022-12-23 | 2.58x |
| 2022-12-22 | 2.79x |
| 2022-12-21 | 3.21x |
| 2022-12-20 | 3.00x |
| 2022-12-19 | 3.21x |
| 2022-12-16 | 3.79x |
| 2022-12-15 | 4.00x |
| 2022-12-14 | 4.31x |
| 2022-12-13 | 4.52x |
| 2022-12-12 | 4.15x |
| 2022-12-09 | 3.94x |
| 2022-12-08 | 4.15x |
| 2022-12-07 | 4.15x |
| 2022-12-06 | 4.31x |
| 2022-12-05 | 4.31x |
| 2022-12-02 | 4.42x |
| 2022-12-01 | 4.15x |
| 2022-11-30 | 4.31x |
| 2022-11-29 | 4.08x |
| 2022-11-28 | 4.10x |
| 2022-11-25 | 3.94x |
| 2022-11-23 | 4.10x |
| 2022-11-22 | 4.21x |
| 2022-11-21 | 4.05x |
| 2022-11-18 | 4.78x |
| 2022-11-17 | 4.84x |
| 2022-11-16 | 5.36x |
| 2022-11-15 | 5.41x |
| 2022-11-14 | 5.62x |
| 2022-11-11 | 5.52x |
| 2022-11-10 | 5.15x |
| 2022-11-09 | 4.89x |
| 2022-11-08 | 5.57x |
| 2022-11-07 | 5.73x |
| 2022-11-04 | 6.04x |
| 2022-11-03 | 6.31x |
| 2022-11-02 | 5.99x |
| 2022-11-01 | 6.15x |
| 2022-10-31 | 5.73x |
| 2022-10-28 | 6.36x |
| 2022-10-27 | 5.99x |
| 2022-10-26 | 6.41x |
| 2022-10-25 | 6.36x |
| 2022-10-24 | 5.94x |
| 2022-10-21 | 5.68x |
| 2022-10-20 | 5.26x |
| 2022-10-19 | 4.89x |
| 2022-10-18 | 5.36x |
| 2022-10-17 | 5.36x |
| 2022-10-14 | 5.47x |
| 2022-10-13 | 5.94x |
| 2022-10-12 | 5.99x |
| 2022-10-11 | 6.04x |
| 2022-10-10 | 5.41x |
| 2022-10-07 | 6.10x |
| 2022-10-06 | 6.62x |
| 2022-10-05 | 6.52x |
| 2022-10-04 | 6.62x |
| 2022-10-03 | 6.36x |
| 2022-09-30 | 4.88x |
| 2022-09-29 | 4.72x |
| 2022-09-28 | 5.18x |
| 2022-09-27 | 4.57x |
| 2022-09-26 | 4.21x |
| 2022-09-23 | 4.15x |
| 2022-09-22 | 4.46x |
| 2022-09-21 | 4.57x |
| 2022-09-20 | 5.24x |
| 2022-09-19 | 5.49x |
| 2022-09-16 | 5.91x |
| 2022-09-15 | 6.16x |
| 2022-09-14 | 5.44x |
| 2022-09-13 | 5.55x |
| 2022-09-12 | 5.85x |
| 2022-09-09 | 5.96x |
| 2022-09-08 | 6.06x |
| 2022-09-07 | 5.49x |
| 2022-09-06 | 5.39x |
| 2022-09-02 | 5.85x |
| 2022-09-01 | 5.96x |
| 2022-08-31 | 6.11x |
| 2022-08-30 | 6.21x |
| 2022-08-29 | 6.27x |
| 2022-08-26 | 6.68x |
| 2022-08-25 | 7.25x |
| 2022-08-24 | 7.19x |
| 2022-08-23 | 6.01x |
| 2022-08-22 | 7.25x |
| 2022-08-19 | 7.91x |
| 2022-08-18 | 7.66x |
| 2022-08-17 | 8.74x |
| 2022-08-16 | 9.00x |
| 2022-08-15 | 9.77x |
| 2022-08-12 | 9.10x |
| 2022-08-11 | 9.05x |
| 2022-08-10 | 9.82x |
| 2022-08-09 | 9.61x |
| 2022-08-08 | 9.36x |
| 2022-08-05 | 8.58x |
| 2022-08-04 | 6.11x |
| 2022-08-03 | 4.93x |
| 2022-08-02 | 4.41x |
| 2022-08-01 | 4.31x |
| 2022-07-29 | 4.62x |
| 2022-07-28 | 4.51x |
| 2022-07-27 | 4.57x |
| 2022-07-26 | 4.57x |
| 2022-07-25 | 4.46x |
| 2022-07-22 | 4.93x |
| 2022-07-21 | 5.13x |
| 2022-07-20 | 5.08x |
| 2022-07-19 | 4.98x |
| 2022-07-18 | 4.82x |
| 2022-07-15 | 5.24x |
| 2022-07-14 | 4.88x |
| 2022-07-13 | 5.55x |
| 2022-07-12 | 5.39x |
| 2022-07-11 | 4.72x |
| 2022-07-08 | 4.57x |
| 2022-07-07 | 4.31x |
| 2022-07-06 | 3.54x |
| 2022-07-05 | 3.38x |
| 2022-07-01 | 3.28x |
| 2022-06-30 | 5.45x |
| 2022-06-29 | 4.89x |
| 2022-06-28 | 5.37x |
| 2022-06-27 | 5.69x |
| 2022-06-24 | 5.61x |
| 2022-06-23 | 6.17x |
| 2022-06-22 | 5.05x |
| 2022-06-21 | 5.05x |
| 2022-06-17 | 4.89x |
| 2022-06-16 | 5.69x |
| 2022-06-15 | 4.16x |
| 2022-06-14 | 3.36x |
| 2022-06-13 | 3.92x |
| 2022-06-10 | 4.08x |
| 2022-06-09 | 4.81x |
| 2022-06-08 | 4.97x |
| 2022-06-07 | 4.32x |
| 2022-06-06 | 2.95x |
| 2022-06-03 | 2.03x |
| 2022-06-02 | 1.53x |
| 2022-06-01 | 1.70x |
| 2022-05-31 | 2.02x |
| 2022-05-27 | 1.10x |
| 2022-05-26 | 0.58x |
| 2022-05-25 | 0.61x |
| 2022-05-24 | 0.49x |
| 2022-05-23 | 0.95x |
| 2022-05-20 | 1.33x |
| 2022-05-19 | 1.15x |
| 2022-05-18 | 1.00x |
| 2022-05-17 | 1.69x |
| 2022-05-16 | 1.12x |
| 2022-05-13 | 0.80x |
| 2022-05-12 | 0.51x |
| 2022-05-11 | 0.35x |
| 2022-05-10 | 1.33x |
| 2022-05-09 | 1.18x |
| 2022-05-06 | 1.84x |
| 2022-05-05 | 1.44x |
| 2022-05-04 | 1.37x |
| 2022-05-03 | 1.12x |
| 2022-05-02 | 1.36x |
| 2022-04-29 | 1.09x |
| 2022-04-28 | 1.25x |
| 2022-04-27 | 1.02x |
| 2022-04-26 | 1.47x |
| 2022-04-25 | 2.11x |
| 2022-04-22 | 1.58x |
| 2022-04-21 | 1.75x |
| 2022-04-20 | 2.51x |
| 2022-04-19 | 2.16x |
| 2022-04-18 | 2.05x |
| 2022-04-14 | 3.20x |
| 2022-04-13 | 3.12x |
| 2022-04-12 | 3.44x |
| 2022-04-11 | 3.68x |
| 2022-04-08 | 4.49x |
| 2022-04-07 | 5.69x |
| 2022-04-06 | 5.37x |
| 2022-04-05 | 5.53x |
| 2022-04-04 | 5.93x |
| 2022-04-01 | 5.45x |
